메뉴 건너뛰기




Volumn 30, Issue 10, 2005, Pages

Impact of inhaled corticosteroid-induced oropharyngeal adverse effects on treatment patterns and costs in asthmatic patients: Results from a Delphi panel

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

EID: 27744551806     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (9)

References (32)
  • 1
    • 84872776320 scopus 로고    scopus 로고
    • Summary health statistics for U.S. adults: National Health Interview Survey, 2002
    • National Center for Health Statistics
    • Lethbridge-Cejku M, Schiller JS, Bernadel L. Summary health statistics for U.S. adults: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 2004;10(222).
    • (2004) Vital Health Stat , vol.10 , Issue.222
    • Lethbridge-Cejku, M.1    Schiller, J.S.2    Bernadel, L.3
  • 2
    • 84872776320 scopus 로고    scopus 로고
    • Summary health statistics for U.S. children: National Health Interview Survey, 2002
    • National Center for Health Statistics
    • Dey AN, Schiller JS, Tai DA. Summary health statistics for U.S. children: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 2004;10(222).
    • (2004) Vital Health Stat , vol.10 , Issue.222
    • Dey, A.N.1    Schiller, J.S.2    Tai, D.A.3
  • 4
    • 0035002520 scopus 로고    scopus 로고
    • Understanding the economic burden of asthma
    • Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001;107:S445-448.
    • (2001) J Allergy Clin Immunol , vol.107
    • Gergen, P.J.1
  • 8
    • 0003637883 scopus 로고    scopus 로고
    • Washington, DC: U.S. Department of Health and Human Services
    • National Asthma Education and Prevention Program (NAEPP) Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. Washington, DC: U.S. Department of Health and Human Services; 2002. Available at www.nhlbi.nih.gov. Accessed August 10,2004.
    • (2002) Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002
  • 9
    • 0033611298 scopus 로고    scopus 로고
    • Treatment patterns among adult patients with asthma: Factors associated with overuse of inhaled [beta]-agonists and underuse of inhaled corticosteroids
    • Diette GB, Wu AW, Skinner EA, et al. Treatment patterns among adult patients with asthma: Factors associated with overuse of inhaled [beta]-agonists and underuse of inhaled corticosteroids. Arch Intern Med 1999;159(22):2697- 2704.
    • (1999) Arch Intern Med , vol.159 , Issue.22 , pp. 2697-2704
    • Diette, G.B.1    Wu, A.W.2    Skinner, E.A.3
  • 11
    • 0031724176 scopus 로고    scopus 로고
    • Side effects of inhaled corticosteroids
    • Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998;102(5):705-713.
    • (1998) J Allergy Clin Immunol , vol.102 , Issue.5 , pp. 705-713
    • Toogood, J.H.1
  • 12
    • 0038516811 scopus 로고    scopus 로고
    • Oral candidiasis associated with inhaled corticosteroid use: Comparison of fluticasone and beclomethasone
    • Fukushima C, Matsuse H, Tomari S, et al. Oral candidiasis associated with inhaled corticosteroid use: Comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003;90:646-651.
    • (2003) Ann Allergy Asthma Immunol , vol.90 , pp. 646-651
    • Fukushima, C.1    Matsuse, H.2    Tomari, S.3
  • 13
    • 0141705348 scopus 로고    scopus 로고
    • Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma
    • Dubus JC, Mély L, Huiart L, et al. Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma. Fundam Clin Pharmacol 2003;17:627-631.
    • (2003) Fundam Clin Pharmacol , vol.17 , pp. 627-631
    • Dubus, J.C.1    Mély, L.2    Huiart, L.3
  • 14
    • 0034847405 scopus 로고    scopus 로고
    • Local side-effects of inhaled corticosteroids in asthmatic children: Influence of drug, dose, age, and device
    • Dubus JC, Marguet C, Deschildre A, et al. Local side-effects of inhaled corticosteroids in asthmatic children: Influence of drug, dose, age, and device. Allergy 2001;56:944-948.
    • (2001) Allergy , vol.56 , pp. 944-948
    • Dubus, J.C.1    Marguet, C.2    Deschildre, A.3
  • 21
    • 0033873221 scopus 로고    scopus 로고
    • Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma
    • Perruchoud AP, Lundback B, Yigla M, et al. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. Respir Med 2000;94(Suppl B):S35-S41.
    • (2000) Respir Med , vol.94 , Issue.SUPPL. B
    • Perruchoud, A.P.1    Lundback, B.2    Yigla, M.3
  • 22
    • 0034940146 scopus 로고    scopus 로고
    • Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 mcg/day) versus HFA-fluticasone propionate (1000 mcg/day) in patients with asthma
    • Aubier M, Wettenger R, Gans SJM. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 mcg/day) versus HFA-fluticasone propionate (1000 mcg/day) in patients with asthma. Respir Med 2001;95:212-220.
    • (2001) Respir Med , vol.95 , pp. 212-220
    • Aubier, M.1    Wettenger, R.2    Gans, S.J.M.3
  • 23
    • 0033044660 scopus 로고    scopus 로고
    • Fluticasone propionate powder: Oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma (Part 1)
    • Nelson HS, Busse WW, deBoisblanc BP, et al. Fluticasone propionate powder: Oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma (Part 1). J Allergy Clin Immunol 1999;102(2):267-275.
    • (1999) J Allergy Clin Immunol , vol.102 , Issue.2 , pp. 267-275
    • Nelson, H.S.1    Busse, W.W.2    DeBoisblanc, B.P.3
  • 24
    • 0030953465 scopus 로고    scopus 로고
    • Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma
    • Pearlman DS, Noonan MJ, Tashkin DP, et al. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol 1997;78(4):356-362.
    • (1997) Ann Allergy Asthma Immunol , vol.78 , Issue.4 , pp. 356-362
    • Pearlman, D.S.1    Noonan, M.J.2    Tashkin, D.P.3
  • 25
    • 0031835117 scopus 로고    scopus 로고
    • Clinical adverse effects of inhaled corticosteroids: Results of a questionnaire survey of asthma specialists
    • Storms WW, Theen C. Clinical adverse effects of inhaled corticosteroids: Results of a questionnaire survey of asthma specialists. Ann Allergy Asthma Immunol 1998;80:391-394.
    • (1998) Ann Allergy Asthma Immunol , vol.80 , pp. 391-394
    • Storms, W.W.1    Theen, C.2
  • 26
    • 0029010454 scopus 로고
    • Frequency of voice problems and cough in patients using pressurized aerosol steroid preparations
    • Williamson IJ, Matusiewicz SP, Brown PH, et al. Frequency of voice problems and cough in patients using pressurized aerosol steroid preparations. Eur Respir J 1995;8:590-592.
    • (1995) Eur Respir J , vol.8 , pp. 590-592
    • Williamson, I.J.1    Matusiewicz, S.P.2    Brown, P.H.3
  • 27
    • 0034303001 scopus 로고    scopus 로고
    • Research guidelines for the Delphi survey technique
    • Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique.J Adv Nurs 2000;32(4):1008-1015.
    • (2000) J Adv Nurs , vol.32 , Issue.4 , pp. 1008-1015
    • Hasson, F.1    Keeney, S.2    McKenna, H.3
  • 28
    • 85067535616 scopus 로고    scopus 로고
    • Duluth, GA: MAG Mutual Healthcare Solutions, Inc.
    • 2004 Physicians' Fee and Coding Guide. Duluth, GA: MAG Mutual Healthcare Solutions, Inc.
    • 2004 Physicians' Fee and Coding Guide
  • 29
    • 0242417034 scopus 로고    scopus 로고
    • The use of inhaled corticosteroids in the United Kingdom and the Netherlands
    • Van Staa TP, Cooper C, Leufkens HG, et al. The use of inhaled corticosteroids in the United Kingdom and the Netherlands. Respir Med 2003;97(5):578-585.
    • (2003) Respir Med , vol.97 , Issue.5 , pp. 578-585
    • Van Staa, T.P.1    Cooper, C.2    Leufkens, H.G.3
  • 30
    • 3142655932 scopus 로고    scopus 로고
    • Pharmacological management to reduce exacerbations in adults with asthma: A systematic review and meta-analysis
    • Sin DD, Man J, Sharpe H, et al. Pharmacological management to reduce exacerbations in adults with asthma: A systematic review and meta-analysis. JAMA 2004;292(3):367-376.
    • (2004) JAMA , vol.292 , Issue.3 , pp. 367-376
    • Sin, D.D.1    Man, J.2    Sharpe, H.3
  • 31
    • 0042201864 scopus 로고    scopus 로고
    • Drug development for asthma
    • Holtzman MJ. Drug development for asthma. Am J Respir 2003;29:163-171.
    • (2003) Am J Respir , vol.29 , pp. 163-171
    • Holtzman, M.J.1
  • 32
    • 5444253912 scopus 로고    scopus 로고
    • Ciclesonide: A novel inhaled corticosteroid
    • Humbert M. Ciclesonide: A novel inhaled corticosteroid. Expert Opin Invest Drugs 2004;13(10):1349-1360.
    • (2004) Expert Opin Invest Drugs , vol.13 , Issue.10 , pp. 1349-1360
    • Humbert, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.